Eversana has acquired pharmaphorum parent Healthware Group in a move that elevates the longstanding partnership between the companies, expands their geographic reach, and
Frontiers Health returns next month, FH23 taking place in the Italian capital of Rome between Wednesday 8th and Friday 10th November, that latter day especially set aside this year for the
After the breakneck pace of development in the digital health category during the pandemic, 2023 looks like it could be a pivotal year, with financing levels falling and t
Healthware Group has released the expert opinion report, ‘Digital therapeutics to enhance the care pathways for depression across the national health service: expert propo
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS